• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Exclusives
    • Nutraceuticals
    • Markets
    • Health
    • Jobs
    • Events
    • Buyers' Guide
    • Showcases
    • More
  • Magazine
  • News
  • Exclusives
  • Nutraceuticals
  • Markets
  • Health
  • Jobs
  • Events
  • Buyers' Guide
  • Showcases
  • Current & Past Issues
    Features
    Columns
    Editorials
    Digital Edition
    Subscribe Now
    Advertise Now
    eNewsletter
    Editorial Guidelines
    Top Features
    Fueling Cognitive Health through Nutrition & Supplementation

    2020 State of the Industry: High Expectations

    2020 International Buyers' Guide

    Clean Label Questions: Anything But ‘Short and Sweet’

    Key Trends in Functional Foods & Beverages for 2020
    Breaking News
    Certifications, Approvals and Patents
    Exclusives
    Industry & Market News
    People
    Products
    Regulatory
    Research
    Supplier News
    Live From Shows
    Top News
    Deerland Obtains Certification from Australia’s Therapeutic Goods Administration

    OptiMSM Shown to Improve Hair & Nail Appearance and Condition

    DCC Acquires Contract Manufacturer Ion Laboratories

    AquaCelle Delivery Technology Shown to Improve Omega-3 Absorption

    Mintel Identifies Global Food and Drink Trends Over Next 10 Years
    Exclusives
    Blogs & Guest Articles
    Health E-Insights
    Area Code 420
    eBook
    Antioxidants
    Dairy-Based Ingredients
    Enzymes
    Fatty Acids
    Fiber & Carbohydrates
    Green Foods
    Herbs & Botanicals
    Marine Nutraceuticals
    Minerals
    Omega 3s
    Probiotics & Prebiotics
    Proteins, Peptides, Amino Acids
    Sweeteners
    Vitamins

    OptiMSM Shown to Improve Hair & Nail Appearance and Condition

    AquaCelle Delivery Technology Shown to Improve Omega-3 Absorption

    Cannabinoid Testing & Quality: Michael Poleselli on the VivAssure Standard

    Mood33 to Introduce Hemp-Infused Herbal Teas Featuring Evo Hemp

    Elixinol Gains USDA Organic Certification for CBD Tincture
    Consumer Trends
    Contract Manufacturing
    Cosmeceuticals / Nutricosmetics
    Delivery & Dosage Technologies
    Dietary Supplements
    Flavors & Colors
    Functional Foods & Beverages
    Healthcare Trends
    Medical Nutrition
    Mergers & Acquisitions
    Natural/Organic
    Nutrition Bars
    Packaging
    Pet Nutraceuticals
    Quality & Safety
    Regulations
    Research
    Testing
    World Markets

    OptiMSM Shown to Improve Hair & Nail Appearance and Condition

    DCC Acquires Contract Manufacturer Ion Laboratories

    AquaCelle Delivery Technology Shown to Improve Omega-3 Absorption

    Mintel Identifies Global Food and Drink Trends Over Next 10 Years

    Cannabinoid Testing & Quality: Michael Poleselli on the VivAssure Standard
    Bone & Joint Health
    Cancer Risk
    Cardiovascular Health
    Cognitive Function
    Diabetes & Blood Sugar Management
    Digestive Health
    Energy
    Eye Health
    Healthy Aging
    Immune Function
    Infant & Children's Health
    Inflammation
    Men's Health
    Mood Health & Sleep
    Oral Health
    Sexual & Reproductive Health
    Skin Health
    Sports Nutrition
    Weight Management/Weight Loss
    Women's Health

    Pharmactive Affron Saffron May Help Relieve Depression Symptoms

    Maternal 5-MTHF Levels Predict Fetal Folate Status

    Obesity and Gum Disease May Have Common Connection: Inflammation

    Probiotic Strain Shown to Reduce Symptoms of Infant Colic

    Clinical Trial Confirms Joint Health Benefits of NEM Brand Eggshell Membrane in 7 Days
    Industry Events
    Live From Show Events
    Webinars
    All Companies
    Categories
    Trade Associations
    Company Capabilities
    International Buyers Guide Companies
    MitoCarn (Alfasigma)

    PLT Health Solutions

    ExcelVite Sdn. Bhd.

    Sabinsa Corporation

    BatchMaster Software, Inc.
    Companies
    Product Releases
    News Releases
    Literature / Brochures
    White Papers
    Jobs
    VIdeos
    Services
    Add New Company
    International Buyers Guide Companies
    ExcelVite Sdn. Bhd.

    MitoCarn (Alfasigma)

    Aiya America (Matcha by Aiya)

    Bioenergy Life Science, Inc. (BLS)

    Sabinsa Corporation
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Digital Edition
      • eNewsletter Archive
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
    • Breaking News
    • Buyers' Guide
      • All Companies
      • Categories
      • Trade Associations
      • Company Capabilities
    • Nutraceuticals
      • Antioxidants
      • Dairy-Based Ingredients
      • Enzymes
      • Fatty Acids
      • Fiber & Carbohydrates
      • Green Foods
      • Herbs & Botanicals
      • Marine Nutraceuticals
      • Minerals
      • Omega 3s
      • Probiotics & Prebiotics
      • Proteins, Peptides, Amino Acids
      • Sweeteners
      • Vitamins
    • Markets
      • Consumer Trends
      • Contract Manufacturing
      • Cosmeceuticals / Nutricosmetics
      • Delivery & Dosage Technologies
      • Dietary Supplements
      • Flavors & Colors
      • Functional Foods & Beverages
      • Healthcare Trends
      • Medical Nutrition
      • Mergers & Acquisitions
      • Natural/Organic
      • Nutrition Bars
      • Packaging
      • Pet Nutraceuticals
      • Quality & Safety
      • Regulations
      • Research
      • Testing
      • World Markets
    • Health
      • Bone & Joint Health
      • Cancer Risk
      • Cardiovascular Health
      • Cognitive Function
      • Diabetes & Blood Sugar Management
      • Digestive Health
      • Energy
      • Eye Health
      • Healthy Aging
      • Immune Function
      • Infant & Children's Health
      • Inflammation
      • Men's Health
      • Mood Health & Sleep
      • Oral Health
      • Sexual & Reproductive Health
      • Skin Health
      • Sports Nutrition
      • Weight Management/Weight Loss
      • Women's Health
    • Online Exclusives
    • Webinars
    • Slideshows
    • Blogs & Guest Articles
    • Health E-Insights
    • Videos
    • Podcasts
    • eBook
    • Infographics
    • Whitepapers
    • Research
      • TrendSense
      • Monograph Center
      • White Papers
      • Research News
    • Jobs
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Supplier Showcases
      • Companies
      • Product Releases
      • News Releases
      • Literature / Brochures
      • White Papers
      • Jobs
      • VIdeos
      • Services
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Columns

    Developing Scientific Support for Product Claims

    Generally accepted scientific principles should be used to determine the quality of studies used as evidence to substantiate a claim.

    Developing Scientific Support for Product Claims
    Related CONTENT
    • Ashland Launches Range of Coatings and Binders in Europe
    • Most Americans Concerned About Food & Product Safety, Yet Few Research Claims
    • Preparing for FDA’s New Era of Food Safety
    • DSHEA Discussion: Assessing Standards for Scientific Evidence
    • Plant-Based Sweeteners Offer Natural Appeal
    By Greg Stephens, Windrose Partners & Sanford W. Bigelow, PhD, DABT, Vanguard Global Associates LLC11.05.19
    In recent Business Insights columns Windrose Partners and Vanguard Global Associates have provided an overview of the U.S. regulatory requirements for food (conventional food, foods for special dietary use (FSDU), and medical foods) and dietary supplement products, whether under development or already commercialized. Two earlier columns emphasized requirements related to the regulatory pathway options and product safety requirement. In this issue, we will address the third leg of our regulatory overview: product claims. 

    This summary of regulatory requirements can be used to provide context in developing information to assess product composition and directions for use, product and ingredient safety, claims, regulatory status of ingredients, and the benefits resulting from the intended use of the product.

    Product benefits inform consumers about the purpose of the product, provide rationale for purchase and, after initial use, hopefully a reason to believe in repeat purchase. Product benefits are articulated in the form of claims, which can be viewed as the focal point between product use, science, regulatory requirements, and consumer choice. Once product claims are developed based on health benefit, product developers can find a clear pathway to product commercialization. This involves assembling information needed to satisfy regulatory requirements. Some of the information (e.g., regarding claims) can be used to support sales activities and optimize the market opportunity. 

    Regulatory Overview
    As previously addressed, the primary regulatory categories of food products regulated by the U.S. Food and Drug Administration (FDA) are: conventional food, dietary supplements, foods for special dietary use, and medical foods. These categories are relevant to provide perspective in distinguishing the claims substantiation requirements.

    Developing Claims Substantiation
    FDA and the U.S. Federal Trade Commission (FTC) work together to regulate the food, medical food, and dietary supplement industries. For these products, the FTC regulates advertising and FDA regulates labeling for food and supplement products. Advertising is viewed as product representations made beyond labeling. The intended use of a product is largely determined by use and composition, claims made on the product label, in collateral labeling, and in other promotional materials such as advertising. 

    Labeling is defined as labels and other written, printed, or graphic matter upon any article (product) or any of its containers or wrappers, or matter accompanying the sale of the product. For dietary supplements and foods in general, claims, statements, and representations need to be truthful, not misleading, and substantiated, and must reveal facts that are material to the representations made. Foods, dietary supplements, foods for special dietary use, and medical foods are all capable of affecting the structure and function of the human body, and as such, are excluded from the definition of drugs. 

    Advertising claims for foods are regulated by the FTC. The FTC does not determine whether claims classify the product as a drug, food, device, or cosmetic product (which is FDA’s responsibility), yet the FTC is responsible for regulating whether the claims are adequately substantiated prior to advertising. 

    According to FTC guidance for advertising claims made for food and dietary supplement products (FTC 1994, 1998, 2001), advertising claims must not be false or misleading, and must be substantiated at the time they are made. Advertisers are required to have a reasonable basis for concluding that advertising claims are accurate, and that representations of claims made in advertising have a particular level of substantiation.

    For many claims (i.e., objective claims) made in advertising (FTC 1994, 1998, 2001), the advertiser needs competent and reliable scientific evidence, including tests, analyses, research, studies, or other evidence based on the expertise of professionals in the relevant area. Evidence should be evaluated in an objective manner by persons qualified to do so, using procedures generally accepted by the profession to yield accurate and reliable results.

    The level of substantiation depends on a number of issues, commonly referred to as the Pfizer factors: the type of claim, the product, the consequences of a false claim, the benefits of a truthful claim, the costs for developing substantiation for the claim, and the amount of substantiation experts in the field believe is reasonable. The FTC uses these factors to determine whether a reasonable basis exists for advertising claims for food, medical food, and supplement products. 

    Types of Claims Made in Product Labeling
    Companies may make the following types of health-related claims in food and supplement product labeling: structure/function claims, health claims, medical food claims, and nutrient content claims.

    Structure/function claims describe the relationship between the ingestion of a food or food component (e.g., nutrient) and how it affects the structure and function of the body (e.g., “calcium builds strong bones”). FDA has recognized structure/function claims for conventional foods since before the 1960s, well before enactment of the Nutrition Labeling and Education Act (NLEA) and the Dietary Supplement Health and Education Act (DSHEA).

    Health claims may also describe the relationship between the ingestion of a food component of nutritive value and the risk of a prevalent disease or a health-related condition, and must be approved by
    the FDA.

    Medical food claims encompass the specific dietary management of general outcomes and/or specific clinical endpoint(s) associated with disease(s) possessing distinctive nutritional requirements. Nutrient content claims are made on all categories of food products that, per serving, describe the level of a nutrient including vitamins and minerals with established daily requirements for dietary intake; nutrient content claims must be approved by the FDA. 

    Food and dietary supplement marketers are allowed to make structure/function claims in product labeling without obtaining FDA approval. Truthful and not misleading structure/function claims that describe the role of a nutrient or dietary ingredient to maintain such structure or function, in and of themselves, and made in the proper context, are acceptable for use in labeling. 

    Requirements for Claims Related to Nutrient Action
    Generally speaking, the quality and quantity of the evidence must match the nature and specificity of the claim. The action of nutrients used as ingredients in products can be attributed to their nutritive value. Nutritive value is often considered as a regulatory basis for adding such ingredients to food products (i.e., for its technical effect). As opposed to any pharmacological effect, foods are typically used for their taste, aroma, or nutritive value, although other foods such as coffee and prune juice may be used for other purposes (Nutrilab v. Schweicker, 713F, 2d 335, 338 (7th Cir. 1983)).

    Dietary supplements, foods for special dietary use, and medical foods are typically not used for their taste and aroma but can be used for their nutritive value. Nutritive value often serves as the basis for distinguishing the use of a product as a food or dietary supplement versus its use as a drug. The FDA (1993) has defined nutritive value, as follows: “... a value in sustaining human existence by such processes as promoting growth, replacing loss of essential nutrients, or providing energy.”

    Both the FTC and FDA require that claims be substantiated, yet these agencies typically do not specify the exact quality and quantity of evidence, and they provide a flexible approach for manufacturers to develop evidence to support particular claims made in product labeling.  

    FDA and FTC will consider all relevant information in their review of evidence that supports claims. Generally accepted scientific and statistical principles should be used to determine the quality of the studies used as evidence to substantiate a claim.

    Consistent with the statutory and regulatory definitions of medical foods, their use is established by medical evaluation (e.g., clinical research) based on recognized scientific principles (such as reproducibility based on repeated findings, validated primary clinical measure based on biologically relevant endpoints, reliable analytical tests, etc.). 

    The FDA has provided sufficient latitude for manufacturers to design and conduct clinical tests in their effort to substantiate product claims. FDA (2002) issued guidance for industry to consider the following factors in substantiating claims made in labeling:  1) the meaning of the claim(s), 2) the relationship of the evidence to the claim, 3) the quality of the evidence; and 4) the totality of the evidence. It is important to understand the meaning of the claim to the consumer, as manufacturers need to substantiate statements before commercialization. 

    On many occasions, in guidance and in enforcement actions, FTC and FDA have elaborated on the scientific parameters for designing and conducting clinical studies needed to substantiate claims. The studies being used as substantiation for product claims need to adequately identify and characterize that the product used in studies is relevant to its conditions of use by consumers. 

    The quality of the scientific studies is based on several criteria including generally accepted scientific principles, appropriate study population, study design and conduct (e.g., presence of a placebo control), adequate duration to measure the effect(s) of interest, data collection, statistical analysis, and outcome measures. When such studies address this criteria, they can be considered of high quality.

    The FDA and FTC “gold standard” for clinical evidence is the randomized, double-blind, placebo-controlled clinical trial design, yet employing such study designs is not a regulatory requirement. Other studies, including in vitro and animal studies, can be helpful to define the mechanism of nutrient action and can augment the clinical findings. 

    In determining whether there is adequate evidence to substantiate a claim, FDA (2008) has asserted in guidance that one should consider the strength of the entire body of evidence, including criteria such as quality, quantity (i.e., number of various types of studies and subject sample sizes), relevance of exposure, and consistency and replication of the findings.

    To determine whether the available scientific evidence is adequate to substantiate a claim, it is important to consider all relevant research, both favorable and unfavorable, and conclude that, on balance, the claim can be substantiated by the scientific evidence. The “weight of the evidence” approach (evaluating both supporting and contradictory findings) is favored by the FDA compared to the “strength of the evidence” approach (i.e., relying on supporting findings only). Conflicting or inconsistent results may raise questions as to whether a particular claim is adequately substantiated, unless a plausible explanation of the issues is provided, such as flaws in the design of a study with an unfavorable finding.  

    Product claims serve to provide consumers and healthcare professionals with information to help determine which products are most appropriate. The quality and quantity of clinical research supporting nutritional products have increased significantly over the last decade. Substantiated by this research, the quality of product clams has improved as well, leading to both increased consumer awareness and greater product knowledge by healthcare professionals. 

    With that said, the risk of pushing clams beyond the scope of the substantiating research is no longer limited to simply receiving an FDA “Warning Letter.” Recent class action litigation and other civil suits (e.g., brought by state attorneys general) have created a significant financial risk to companies. Thus, the investment in clinical research, implementing sound regulatory practices, GMP manufacturing, and drafting well substantiated label claims will continue to drive strong category growth.

    References
    • FDA 1993. Nutrition Labeling and Education Act. Final Rule. 58 Federal Register 2079 (January 6, 1993). 
    • FDA  2002.  Structure Functions Claims.  found at https://www.fda.gov/food/food-labeling-nutrition/structurefunction-claims, and  found  at: Small Entity Compliance Guide on Structure/Function Claims https://www.fda.gov/regulatory-information/search-fda-guidance-documents/small-entity-compliance-guide-structurefunction-claims, January 2002. 
    • FDA 2014. Food Allergens.  https://www.fda.gov/food/food-ingredients-packaging/food-allergens. Accessed March 28, 2016. 
    • FTC 1994. Enforcement Policy Statement on Food Advertising, May 1994. Federal Trade Commission, Washington, DC.; 59 Federal Register 28388; June 1, 1994. 
    • FTC 1998. Dietary Supplements: An Advertising Guide for Industry, Bureau of Consumer Protection, Federal Trade Commission, 26 pp. 
    • FTC 2001. Dietary Supplements: An Advertising Guide for Industry, Bureau of Consumer Protection, Federal Trade Commission, pp. 32. NW
    Related Searches
    • fda
    • Medical Foods
    • Calcium
    • Nutrient
    Related Knowledge Center
    • Testing
    • Quality & Safety
    • Healthcare Trends
    Suggested For You
    AHPA President Michael McGuffin Discusses Challenges & Opportunities for Hemp & CBD AHPA President Michael McGuffin Discusses Challenges & Opportunities for Hemp & CBD
    Partnership with Federal Agencies Targets Food Waste Reduction Partnership with Federal Agencies Targets Food Waste Reduction
    Windrose Partners LLC Windrose Partners LLC
    Federal Agencies Warn Company Marketing Unapproved CBD Products Federal Agencies Warn Company Marketing Unapproved CBD Products
    White Paper Uncovers How Nutrition and Clean Label Trends Shape Future of Food White Paper Uncovers How Nutrition and Clean Label Trends Shape Future of Food
    Clinical Nutrition: A New Market Opportunity Clinical Nutrition: A New Market Opportunity
    CBD Regulatory Status Update: The Chaos Continues CBD Regulatory Status Update: The Chaos Continues
    Happy Pets, Happy Consumers: Developing On-Trend Pet Nutrition Products Happy Pets, Happy Consumers: Developing On-Trend Pet Nutrition Products
    The CBD Craze: Still Only the Beginning The CBD Craze: Still Only the Beginning
    Resveratrol: The Healthy Aging Nutrient Resveratrol: The Healthy Aging Nutrient
    FDA Approves Impossible Foods Petition, Allows Soy Leghemoglobin as Color Additive FDA Approves Impossible Foods Petition, Allows Soy Leghemoglobin as Color Additive
    Industry Calls for Label Literacy of New Supplement Facts Label Industry Calls for Label Literacy of New Supplement Facts Label
    FDA Allows Claims for EPA/DHA Omega-3 and Risk of Hypertension & Coronary Heart Disease FDA Allows Claims for EPA/DHA Omega-3 and Risk of Hypertension & Coronary Heart Disease
    FDA Warns Women of Childbearing Age to Avoid Vinpocetine FDA Warns Women of Childbearing Age to Avoid Vinpocetine
    Preparing for FDA’s New Era of Food Safety Preparing for FDA’s New Era of Food Safety

    Related Columns

    • Dietary Supplements | Herbs & Botanicals | Natural/Organic | Quality & Safety | Regulations | Testing
      The Wild West Sells More than Just CBD

      The Wild West Sells More than Just CBD

      Self-determined GRAS is not a cure-all for NDINs, so be responsible and conduct the necessary safety and toxicology work.
      By Todd Harrison, Venable 11.05.19

    • Regulations | World Markets
      Regulatory Harmonization in Europe: Setting Daily Reference Values

      Regulatory Harmonization in Europe: Setting Daily Reference Values

      Maximum intake amounts of many micronutrients are still not regulated throughout the EU.
      By Joerg Gruenwald, analyze & realize ag 11.05.19

    • Dietary Supplements | Healthcare Trends | Herbs & Botanicals | Quality & Safety | Research | Testing
      Botanical Science: Post-Exercise Benefits & Neuroprotective Potential

      Botanical Science: Post-Exercise Benefits & Neuroprotective Potential

      AHPA compiles recent research on botanicals and plant compounds published in peer-reviewed journals.
      By Holly Johnson, PhD, American Herbal Products Association (AHPA) 11.05.19


    • Dietary Supplements | Healthcare Trends | Herbs & Botanicals | Medical Nutrition | Quality & Safety | Regulations
      CBD in the Clinic: How Practitioners View Life After the Farm Bill

      CBD in the Clinic: How Practitioners View Life After the Farm Bill

      Holistic, functional medicine practitioners see therapeutic value of CBD and have confidence in its efficacy for a range of common health concerns.
      By Erik Goldman, Holistic Primary Care 10.07.19

    • Dietary Supplements | Healthcare Trends | Herbs & Botanicals | Quality & Safety | Regulations
      CBD Insurance: ‘The Perfume of the Premium’ Strengthens

      CBD Insurance: ‘The Perfume of the Premium’ Strengthens

      The insurance marketplace for hemp growers and CBD manufacturers will continue to expand.
      By Sheldon Baker, Baker Dillon Group LLC 10.07.19

    • Antioxidants | Dietary Supplements | Digestive Health | Herbs & Botanicals | Minerals | Research | Vitamins
      Cinnamon: A Journey from Traditional Flavor to Modern Health Applications

      Cinnamon: A Journey from Traditional Flavor to Modern Health Applications

      A remedy for many ailments in Ayurvedic medicine, science continues to uncover new uses for this common flavoring agent.
      By Dilip Ghosh, PhD, FACN, nutriConnect 10.07.19


    • Dietary Supplements | Healthcare Trends | Quality & Safety | Regulations
      Clinical Nutrition: A New Market Opportunity

      Clinical Nutrition: A New Market Opportunity

      Clearer language and scientific documentation for product benefits could open new doors for nutraceuticals in healthcare settings.
      By Greg Stephens, Windrose Partners, & Sheila Campbell, PhD, RD 09.09.19

    • Dietary Supplements | Herbs & Botanicals | Quality & Safety | Regulations
      CBD Regulatory Status Update: The Chaos Continues

      CBD Regulatory Status Update: The Chaos Continues

      FDA already has the authority to create a legal pathway for cannabidiol. It just needs the will to implement it.
      By Todd Harrison, Venable 09.09.19

    • Dietary Supplements | Healthcare Trends | Herbs & Botanicals | Regulations | World Markets
      Regulatory Harmonization in Europe: CBD Case Study

      Regulatory Harmonization in Europe: CBD Case Study

      Despite long-standing efforts, many EU regulatory standards are still out of alignment.
      By Joerg Gruenwald, analyze & realize ag 09.09.19


    • Herbs & Botanicals | Quality & Safety | Regulations | Testing
      Mile High Labs: Stephen Mueller & The Mile High Monster

      Mile High Labs: Stephen Mueller & The Mile High Monster

      As chief technology officer and founder, he is the technical visionary of Mile High Labs and is designing/building and operating the future of hemp extraction.
      By Sheldon Baker, Baker Dillon Group LLC 07.03.19

    • Dietary Supplements | Regulations | World Markets
      Australia: Leading Regulation of Complementary Medicines

      Australia: Leading Regulation of Complementary Medicines

      The TGA recently implemented a Compliance Rating Scheme for listed medicines.
      By Dilip Ghosh, PhD, FACN, nutriConnect 07.03.19

    • Dietary Supplements | Regulations
      DSHEA Discussion: Assessing Standards for Scientific Evidence

      DSHEA Discussion: Assessing Standards for Scientific Evidence

      Adjusting the health claims system could encourage more clinical trials and benefit consumers.
      By Todd Harrison, Venable 06.03.19

    • Dietary Supplements | Regulations | World Markets
      Non-Specific Health Claims: Beyond the Letter of the Law

      Non-Specific Health Claims: Beyond the Letter of the Law

      These statements are acceptable as long as they are either accepted generic descriptors or accompanied by a specific health claim.
      By Joerg Gruenwald, analyze & realize ag 06.03.19

    • Dietary Supplements | Healthcare Trends | Medical Nutrition | Regulations
      Engaging Doctors in the Dialogue About ‘DSHEA 2.0’

      Engaging Doctors in the Dialogue About ‘DSHEA 2.0’

      The need for clear and truthful clinical communication should be on the table for discussion as DSHEA goes under review.
      By Erik Goldman, Holistic Primary Care 05.02.19

    • Dietary Supplements | Healthcare Trends | Herbs & Botanicals | Quality & Safety | Regulations
      ‘Can I Get Liability Insurance for My ‘Illegal’ CBD Products?

      ‘Can I Get Liability Insurance for My ‘Illegal’ CBD Products?

      The short answer is yes, but let’s explore in more detail.
      By Greg Doherty, Bolton & Company 05.02.19

    Breaking News
    • Deerland Obtains Certification from Australia’s Therapeutic Goods Administration
    • OptiMSM Shown to Improve Hair & Nail Appearance and Condition
    • DCC Acquires Contract Manufacturer Ion Laboratories
    • AquaCelle Delivery Technology Shown to Improve Omega-3 Absorption
    • Mintel Identifies Global Food and Drink Trends Over Next 10 Years
    View Breaking News >
    CURRENT ISSUE

    December 2019

    • 2020 International Buyers' Guide
    • 2020 State of the Industry: High Expectations
    • Fueling Cognitive Health through Nutrition & Supplementation
    • View More >
    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Deerland Obtains Certification from Australia’s Therapeutic Goods Administration
    OptiMSM Shown to Improve Hair & Nail Appearance and Condition
    DCC Acquires Contract Manufacturer Ion Laboratories
    Coatings World

    Latest Breaking News From Coatings World

    Palmer Holland Expands Sales Team into Canada
    Axalta Reports 'Oustanding' Feedback on Award-Winning Voltatex 4224
    Sika Opens 3rd Indonesian Plant
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    FDA Approves First Nasal Rescue Treatment for Frequent Seizure Activity
    Lens-Free Microendoscope Generates High Quality Images
    Roche's Blood Glucose Reading Smartphone App Gains CE Mark
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Charles River, Bit Bio Enter Strategic Partnership
    Parexel Adds Experts to Regulatory Consulting Group
    Catalent, Bridge Therapeutics Execute Exclusive License Agreement
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    CES 2020 Preview - Innovation Award Honorees in Health & Wellness
    Star of E!'s Botched Gets Line Leaping Bunny Certified
    Verve Medical Cosmetics Celebrates 20 Years
    Happi

    Latest Breaking News From Happi

    Jennifer Garner Joins Virtue Labs
    Perfect Corp. Partners with Sally Beauty
    Dollar General To Sell CBD Beauty
    Ink World

    Latest Breaking News From Ink World

    ePac Flexible Packaging Expands into Asia Pacific Market
    Palmer Holland Expands Sales Team into Canada
    Koenig & Bauer Promotes Preston Neetzel to Director of Flexo Sales
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Domino welcomes Steve Daily to Service & Support Team
    Kodak and Uteco sell first Ultrastream flexible packaging press
    Archroma announces CEO transition
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    AATC Adds Two Scholarships
    Archroma Names CEO
    Fitesa Buys Freudenberg's South American Hygiene Business
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    FDA OKs Shoulder Innovations' Augmented Glenoids for Total Shoulder System
    OrthoGrid Systems Receives FDA 510(k) Clearance for New PhantomMSK Trauma Application
    Tyber Medical Opens $8M Office and Manufacturing Facility
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Ynvisible, Identiv Partner
    Tom Peregoodoff Appointed CEO of TF Massif Technologies
    Osram’s Managing Board Invites ams to Talks About Future

    Copyright © 2019 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.